FDA fast-tracks EO2463 immunotherapy for follicular lymphoma, promising a new treatment option backed by positive trial data ...

A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the ...

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the ...

Various treatments are available for lymphoma, including chemotherapy, radiation, immunotherapy, targeted therapy, or a bone marrow transplant. A doctor or specialist can recommend which treatment is ...

At Ochsner Cancer Center of Acadiana, people diagnosed with blood cancers find more than the latest treatments — they also ...

Discover innovative immunotherapy strategies that leverage the immune system to combat hematological malignancies effectively ...

Dr. Brian Till is both a physician and a cancer researcher who works at Fred Hutch Cancer Center. He balances dual roles as a board-certified medical oncologist who treats patients with lymphomas ...